KARPINSKI; Piotr H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for KARPINSKI; Piotr H..The latest application filed is for "hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-be- nzyl]-azetidine-3-carboxylic acid".

Company Profile

1.21.33

KARPINSKI; Piotr H. - Lincoln Park NJ
Karpinski; Piotr H. - East Hanover NJ
Karpinski; Piotr H - Lincoln Park NJ
Karpinski; Piotr H. - Lincon Park NJ
Karpinski; Piotr H. - Fairport NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hemifumarate Salt Of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-be- Nzyl]-azetidine-3-carboxylic Acid App 20210323915 - CISZEWSKI; Lech ; et al.	2021-10-21
Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors Grant 10,421,755 - Marterer , et al. Sept	2019-09-24
Hemifumarate Salt Of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-be- Nzyl]-azetidine-3-carboxylic Acid App 20180118678 - CISZEWSKI; Lech ; et al.	2018-05-03
Salts Of Aza-bicyclic Di-aryl Ethers And Methods To Make Them Or Their Precursors App 20180009801 - Marterer; Wolfgang ; et al.	2018-01-11
Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors Grant 9,802,931 - Marterer , et al. October 31, 2	2017-10-31
Crystalline Forms Of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propan- E-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine App 20160175305 - Feng; Lili ; et al.	2016-06-23
Salts of aza-bicyclic di-aryl ethers and pharmaceuticals thereof Grant 9,365,565 - Marterer , et al. June 14, 2	2016-06-14
Salts Of Aza-bicyclic Di-aryl Ethers And Methods To Make Them Or Their Precursors App 20160145253 - Marterer; Wolfgang ; et al.	2016-05-26
Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propan- e-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine Grant 9,309,229 - Feng , et al. April 12, 2	2016-04-12
Manufacturing process for pyrimidine derivatives Grant 9,181,215 - De La Cruz , et al. November 10, 2	2015-11-10
Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-- 3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide Grant 9,163,005 - Manley , et al. October 20, 2	2015-10-20
Hemifumarate Salt Of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-be- Nzyl]-azetidine-3-carboxylic Acid App 20150175536 - CISZEWSKI; Lech ; et al.	2015-06-25
Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyr- idin-3-yl-pyrimidin-2-ylamino)-benzamide App 20140343087 - Manley; Paul W. ; et al.	2014-11-20
Salts Of Aza-bicyclic Di-aryl Ethers And Methods To Make Them Or Their Precursors App 20140220125 - Marterer; Wolfgang ; et al.	2014-08-07
Salts Grant 8,697,682 - De La Cruz , et al. April 15, 2	2014-04-15
Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-- 3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide App 20140038994 - MANLEY; Paul W. ; et al.	2014-02-06
Hemifumarate Salt Of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-be- Nzyl]-azetidine-3-carboxylic Acid App 20140005162 - CISZEWSKI; Lech ; et al.	2014-01-02
Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl- -pyrimidin-2-ylamino)-benzamide Grant 8,580,806 - Manley , et al. November 12, 2	2013-11-12
Crystalline Forms Of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propan- E-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine App 20130274279 - Feng; Lili ; et al.	2013-10-17
Manufacturing Process For Pyrimidine Derivatives App 20130225571 - Calienni; John Vincent ; et al.	2013-08-29
Salts App 20130225550 - DE LA CRUZ; Marilyn ; et al.	2013-08-29
Salts Grant 8,486,930 - De La Cruz , et al. July 16, 2	2013-07-16
Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-- 3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide App 20130137712 - Manley; Paul W. ; et al.	2013-05-30
Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl- -pyrimidin-2-ylamino)-benzamide Grant 8,389,537 - Manley , et al. March 5, 2	2013-03-05
Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyr- idin-3-yl-pyrimidin-2-ylamino)-benzamide App 20130023548 - MANLEY; Paul W. ; et al.	2013-01-24
Salts Of Benzimidazolyl Pyridyl Ethers And Formulations Thereof App 20120308651 - Gullapalli; Rampurna ; et al.	2012-12-06
Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-- 3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide App 20120270891 - Manley; Paul W. ; et al.	2012-10-25
Salts of benzimidazolyl pyridyl ethers and formulations thereof Grant 8,202,998 - Gullapalli , et al. June 19, 2	2012-06-19
Hemifumarate Salt Of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-be- Nzyl]-azetidine-3-carboxylic Acid App 20120115840 - Ciszewski; Lech ; et al.	2012-05-10
Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-- 3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-Benzamide Grant 8,163,904 - Manley , et al. April 24, 2	2012-04-24
New Salts App 20110257150 - De La Cruz; Marilyn ; et al.	2011-10-20
Salts and crystal modifications thereof Grant 7,977,330 - Feng , et al. July 12, 2	2011-07-12
Salts Of Benzimidazolyl Pyridyl Ethers And Formulations Thereof App 20100168060 - Gullapalli; Rampurna ; et al.	2010-07-01
Salts and Crystal Modifications Thereof App 20090163478 - Feng; Lili ; et al.	2009-06-25
Crystalline Forms of 4-Methyl-N- [3-(4-Methyl-Imidazol-1-Yl)-5-Trifluoromethyl-Phenyl]-3- (4-Pyridin-3-Yl-Pyrimidin-2-Ylamino) -Benzamide App 20080269269 - Manley; Paul W. ; et al.	2008-10-30
Salts of 4-Methyl-N-[3-(4-Methyl-Imidazol-1-Yl)-5-Trifluoromethyl-Phenyl]-- 3-(4-Pyridin-3-Yl-Pyrimidin-2-Ylamino)-Benzamide App 20080200487 - Manley; Paul W. ; et al.	2008-08-21
Microprecipitation of nanoparticulate pharmaceutical agents Grant 5,560,932 - Bagchi , et al. October 1, 1	1996-10-01
Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents Grant 5,401,492 - Kellar , et al. March 28, 1	1995-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.